Synthesis and effects of pyrazolines and isoxazoles on the phagocytic chemotaxis and release of reactive oxygen species by zymosan stimulated human neutrophils

Medicinal Chemistry

Volumn 9, Issue 8, 2013, Pages 1091-1098

  Bukhari, Syed Nasir Abbas ^a   Jantan, Ibrahim ^a   Wai, Lam Kok ^a   Lajis, Nordin Haji ^b   Abbas, Faridah ^b   Jasamai, Malina ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Chemiluminescence; Chemotactic activity; Immunomodulatory; Isoxazoles; Pyrazolines

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; ISOXAZOLE DERIVATIVE; PHENAZONE; PYRAZOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; ZYMOSAN; PYRAZOLE DERIVATIVE;

ARTICLE; CELL MIGRATION; CHEMOLUMINESCENCE; CHEMOTAXIS; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; INNATE IMMUNITY; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; LUMINESCENCE; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CELL SURVIVAL; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOXAZOLES; LUMINESCENCE; MOLECULAR STRUCTURE; NEUTROPHILS; PHAGOCYTES; PHAGOCYTOSIS; PYRAZOLES; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP; ZYMOSAN;

EID: 84890266315     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411309080011     Document Type: Article

References (25)

1. Kaplancikli, Z. A.; Özdemir, A.; Turan-Zitouni, G.; Altintop, M. D.; Can, Ö. D. New pyrazoline derivatives and their antidepressant activity. Eur. J. Med. Chem., 2010, 45, 4383-7.
2. Shaharyar, M.; Abdullah, M. M.; Bakht, M. A.; Majeed, J. Pyrazoline bearing benzimidazoles: Search for anticancer agent. Eur. J. Med. Chem., 2010, 45, 114-9.
3. Taj, T.; Kamble, R. R.; Gireesh, T. M.; Hunnur, R. K.; Margankop, S. B. One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities. Eur. J. Med. Chem., 2011, 46, 4366-73.
4. Chandra, T.; Garg, N.; Lata, S.; Saxena, K. K.; Kumar, A. Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity. Eur. J. Med. Chem., 2010, 45, 1772-6.
5. Acharya, B. N.; Saraswat, D.; Tiwari, M.; Shrivastava, A. K.; Ghorpade, R.; Bapna, S.; Kaushik, M. P. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur. J. Med. Chem., 2010, 45, 430-8.
6. Dawane, B. S.; Konda, S. G.; Mandawad, G. G.; Shaikh, B. M. Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4′-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H- imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur. J. Med. Chem., 2010, 45, 387-92.
7. Amnerkar, N. D.; Bhusari, K. P. Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetylpyrazolin derivatives of aminobenzothiazole. Eur. J. Med. Chem., 2010, 45, 149-59.
8. Silva, N. M.; Tributino, J. L. M.; Miranda, A. L. P.; Barreiro, E. J.; Fraga, C. A. M. New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidates. Eur. J. Med. Chem., 2002, 37, 163-70.
9. Swati, O.; Archita, B.; Ganpat, L. Synthetic and pharmacological studies on some 1-isonicotinoyl-3-methyl-4-(4-substituted phenyl)-3a,4-dihydro pyrazolo [3,4a-c]pyrazoles and their ethoxyphthalimide derivatives. Arkivoc, 2008, 11, 112-22.
10. Solankee, A.; Prajapati, Y. An efficient synthesis of some new fluorine containing acetyl pyrazoline and isoxazole derivatives and their antibacterial activity. RASAYAN J. Chem., 2009, 2 23-7.
11. Beutler, B. Innate immunity: an overview. Mol. Immunol., 2004, 40, 845-59.
12. Stephens, L.; Milne, L.; Hawkins, P. Moving towards a better understanding of chemotaxis. Curr. Biol., 2008, 18, 485-94.
13. van Eeden, S. F.; Klut, M. E.; Walker, B. A.; Hogg, J. C. The use of flow cytometry to measure neutrophil function. J. Immunol. Meth., 1999, 232, 23-43.
14. Arnhold, J. Free radicals-friends or foes? Properties, functions and secretion of human myeloperoxidase. Biochemistry, 2004, 69, 4-9.
15. Afonso, V.; Champy, R.; Mitrovic, D.; Collin, P.; Lomri, A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine, 2007, 74, 324-9.
16. Lam, K. W.; Uddin, R.; Liew, C. Y.; Tham, C. L.; Israf, D. A.; Syahida, A.; Rahman, M.; Basyaruddin, A.; Ul-Haq, Z.; Lajis, N. H. Synthesis and QSAR analysis of chalcone derivatives as nitric oxide inhibitory agent. Med. Chem. Res., 2012, 21, 1953-66.
17. Zolfigol, M. A.; Chehardoli, G.; Shiri, M. Epoxidation of aromatic α,β unsaturated ketones using PVP-H2O2 under mild and heterogeneous conditions. React. Funct. Polym., 2007, 67, 723-7.
18. Ghoniem, K.M.; Badran, M.M.; Shaaban, M. A.; El-Meligie, S. Reactions of epoxy chalcone analogues with some nucleophilic reagents. Egypt. J. Pharm. Sci., 1988, 29, 563-70.
19. Koko, W. S.; Mesaik, M. A.; Yousof, S.; Galal, M.; Choudary, M. I. In vitro immunomodulating properties of selected Sudanese medicinal plants. J. Ethnopharmacol., 2008, 118, 26-34.
20. Jantan, I.; Harun, N. H.; Septama, A. W.; Murad, S.; Mesaik, M. A. Inhibition of chemiluminescence and chemotactic activity of phagocytes in vitro by the extracts of selected medicinal plants. J. Nat. Med., 2011, 65, 400-5.
21. Magrisso, M. J.; Alexandrova, M. L.; Bochev, P. G.; Bechev, B. G.; Markova, V. I.; Benchev, I. C. Model components of luminol chemiluminescence generated by PMNL. J. Biochem. Biophys. Meth., 1995, 30, 257-69.
22. Sacerdote, P.; Massi, P.; Panerai, A. E.; Parolaro, D. In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol., 2000, 109, 155-63.
23. Bhatt, A. H.; Parekh, H. H.; Parikh, K. A.; Parikh, A. R. Synthesis of pyrazolines and cyanopyridines as potential antimicrobial agents. Ind. J. Chem., 2001, 40, 57-61.
24. Parij, N.; Nagy, A. M.; Fondu, P.; Nève, J. Effects on non-steroidal anti-inflammatory drugs on the luminol and lucigenin chemiluminescence of human neutrophiles. Eur. J. Pharmacol., 1998, 352, 299-305.
25. Spisani, S.; Vanzini, G.; Traniello, S. Inhibition of human leukocytes locomotion by anti-inflammatory drugs. Experientia, 1979, 1, 803-4.